From the Department of Nuclear Medicine, Hospital Kuala Lumpur, Lumpur.
Department of Nuclear Medicine, Oncology, and Radiotherapy, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, Malaysia.
Clin Nucl Med. 2024 Mar 1;49(3):250-252. doi: 10.1097/RLU.0000000000005037. Epub 2024 Jan 15.
A 57-year-old woman received radioiodine therapy post total thyroidectomy for pT3aNxMx follicular thyroid carcinoma. Posttherapy 131I whole-body scan showed 131I concentration in the chest, mediastinum, and left upper thigh with stimulated thyroglobulin (Tg) of 89 μg/L. Subsequent radioiodine therapies showed persistent 131I accumulation in the anterior mediastinal soft tissue lesions and a hypodense segment VII liver lesion visualized on SPECT/CT, suggestive of iodine-avid metastatic disease despite the undetectable serum Tg (<1.0 μg/L) with no Tg antibody interference. Biopsy of the liver lesion revealed liver cyst, and consequent removal of the mediastinal lesions showed benign thymic cysts.
一位 57 岁女性因 pT3aNxMx 滤泡性甲状腺癌在全甲状腺切除术后接受放射性碘治疗。治疗后 131I 全身扫描显示胸部、纵隔和左大腿有 131I 浓度,刺激后甲状腺球蛋白(Tg)为 89μg/L。随后的放射性碘治疗显示前纵隔软组织病变和 SPECT/CT 上可见的 VII 段肝低密度病变持续有 131I 积聚,提示碘摄取转移疾病,尽管血清 Tg 检测不到(<1.0μg/L)且无 Tg 抗体干扰。肝病变活检显示为肝囊肿,纵隔病变切除后显示为良性胸腺囊肿。